MSLN is a transmembrane glycoprotein relatively specific to mesothelial cells that line body cavities including the peritoneum, but is also highly expressed in many tumour cells including mesothelioma, ovarian and pancreatic cancer. This evidence concerns the gene MSLN and neoplasm.